Plasma atrial natriuretic peptide, renin activity, and aldosterone in changes of body fluid volume after renal transplantation
Sugahara, S.; Koyama, I.; Yoshikawa, Y.; Dohi, Y.; Omoto, R.
Transplantation Proceedings 24(4): 1576-1577
1992
ISSN/ISBN: 0041-1345 PMID: 1386700 Document Number: 391879
Document emailed within 1 workday
Related Documents
Colantonio, D.; Pasqualetti, P.; Casale, R.; Natali, G.; Desiati, P. 1989: Circadian rhythm of atrial natriuretic peptide, plasmatic renin activity, and plasma aldosterone in compensated cirrhosis of the liver American Journal of Gastroenterology 84(2): 209-210Irzyniec, T.; Kokot, F.; Grzeszczak, W. 1991: Activity of the renin-angiotensin-aldosterone (RAA) and secretion of the atrial natriuretic peptide (ANP) in patients with chronic renal failure Materia Medica Polona. Polish Journal of Medicine and Pharmacy 23(2): 125-129
O'Hare, J.P.; Anderson, J.V.; Millar, N.D.; Bloom, S.R.; Corrall, R.J. 1988: The relationship of the renin-angiotensin-aldosterone system to atrial natriuretic peptide and the natriuresis of volume expansion in diabetics with and without proteinuria Postgraduate Medical Journal 64 Suppl. 3: 35-8; Discussion 48-9
Turski, B.K.; Gembicka-Kuzak, D.M.; Debinski, W.B.; Kuzak, W. 1995: Relationship between atrial natriuretic peptide (ANP), renin (PRA), aldosterone (PAC), hemodynamic responses to lower body negative pressure (LBNP) and +Gz tolerance Journal of Gravitational Physiology: a Journal of the International Society for Gravitational Physiology 2(1): P37-P38
Irzyniec, T.; Kokot, F.; Grzeszczak, W.; Klin, M. 1993: Function of the renin-angiotensin-aldosterone system and atrial natriuretic peptide secretion in patients with acute non-inflammatory renal insufficiency Polski Tygodnik Lekarski 48(20-22): 470-474
Aoyama, K.; Ogata, M.; Sata, T.; Shigematsu, A. 1992: Plasma levels of alpha-human atrial natriuretic peptide, renin activity and angiotensin Ii in partial hepatectomy MASUI. Japanese Journal of Anesthesiology 41(1): 37-42
El-Migdadi, F. 2007: A comparative study of plasma renin activity, aldosterone and atrial natriuretic hormone between normotensive and hypertensive people living at below sea level altitude (Jordan Valley) and those residing at moderate altitude above Neuro Endocrinology Letters 28(4): 386-394
Häggström, J.; Hansson, K.; Kvart, C.; Karlberg, B.E.; Vuolteenaho, O.; Olsson, K. 1997: Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs American Journal of Veterinary Research 58(1): 77-82
Li, Y.; Wang, L.; Xue, Z. 1995: The significance of changes in plasma renin angiotensin aldosterone system and atrial natriuretic factor in patients with high altitude myocardial hypoxidosis Zhonghua Nei Ke Za Zhi 34(12): 812-815
Chen, J.H.; Tsai, J.H.; Lai, Y.H.; Hwang, S.J. 1990: Plasma atrial natriuretic peptide in patients with chronic renal failure Journal of the Formosan Medical Association 89(8): 645-650
Eiskjaer, H.; Pedersen, E.B.; Rasmussen, L.M.; Jespersen, B. 1989: Verapamil sustained-release in renal parenchymal hypertension: effect on blood pressure, kidney function, angiotensin II, aldosterone, arginine vasopressin, atrial natriuretic peptide, and lipoproteins Journal of Cardiovascular Pharmacology 13 Suppl. 4: S17-S22
Liu, Y.; Xiao, Y.; Chen, X.; Zhang, F. 2014: Association between plasma brain natriuretic peptide/N-terminal pro-brain natriuretic peptide levels and atrial fibrillation: evidence from a meta-analysis Chinese Medical Journal 127(15): 2824-2828
Pratt, J.H.; Luft, F.C. 1979: The effect of extremely high sodium intake on plasma renin activity, plasma aldosterone concentration, and urinary excretion of aldosterone metabolites Journal of Laboratory and Clinical Medicine 93(5): 724-729
Ocón, J.; Piña, C.; Castellet, R.; Vila, R.; del Río, G.; Arnau, C. 1985: Clinical evaluation of penbutolol (Hoe 893d) (beta adrenergic blocker), alone and in combination with hydrochlorothiazide, in the treatment of arterial hypertension. II. Effect on plasma electrolytes, renal function, plasma renin and aldosterone activity and risk factors, including plasma lipids Medicina Clinica 85(2): 53-57
Opgenorth, T.J.; Burnett, J.C.; Granger, J.P.; Scriven, T.A. 1986: Effects of atrial natriuretic peptide on renin secretion in nonfiltering kidney American Journal of Physiology 250(5 Pt 2): F798-F801
Williams, T.D.; Walsh, K.P.; Lightman, S.L.; Sutton, R. 1988: Atrial natriuretic peptide inhibits postural release of renin and vasopressin in humans American Journal of Physiology 255(3 Pt 2): R368-R372
Cerasola, G.; Cottone, S.; Mangano, M.T.; D'Ignoto, G.; Pinto, A.; Carone, M.B. 1988: Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension Clinical Therapeutics 10(6): 694-703
Saito, S.; Nishiuchi, T.; Kojima, A. 1987: Atrial natriuretic peptide. Factors regulating release of atrial natriuretic peptide and its metabolism Nihon Rinsho. Japanese Journal of Clinical Medicine 45(11): 2573-2580
Aptel, H.B.; Deacon, C.F.; Henderson, I.W. 1994: Atrial natriuretic peptide in the Milan hypertensive rat and the Milan normotensive rat: plasma concentration and binding to renal glomeruli in young, adult and aged rats Journal of Hypertension 12(11): 1209-1215
Yamaji, T.; Johshita, H.; Ishibashi, M.; Takaku, F.; Teramoto, A. 1989: Atrial natriuretic peptide in human cerebrospinal fluid Journal of Laboratory and Clinical Medicine 114(4): 426-430